Showing results (511-520 of 1,023) with videos related to
Sort By:
Pageof 103
FEBS Letters|December 31, 1997
Saposins (sap) A and C activate the degradation of galactosylceramide in living cellsK Harzer, B C Paton, H Christomanou, et al.Science (New York, N.Y.)|August 26, 1988
Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locusJ S O'Brien, K A Kretz, N Dewji, et al.Leukemia|January 1, 1995
Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromesJ E Cortes, H Kantarjian, S O'Brien, et al.Neuroreport|November 21, 1994
Sequential operation of disconnected cerebral hemispheres in split-brain patientsH Pashler, S J Luck, S A Hillyard, et al.Obstetrics and Gynecology|June 2, 2006
Repair techniques for obstetric anal sphincter injuries: a randomized controlled trialRuwan J Fernando, Abdul H Sultan, Christine Kettle, et al.Transfusion|August 26, 1998
Evaluation and comparison of three mobilization methods for the collection of granulocytesD B Jendiroba, B Lichtiger, E Anaissie, et al.Cancer|January 29, 2000
Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia: correlation with disease progression and response to therapyK Kaban, H Kantarjian, M Talpaz, et al.Annals of Emergency Medicine|November 5, 1997
ED use by older victims of family violenceM S Lachs, C S Williams, S O'Brien, et al.Glycoconjugate Journal|April 1, 1996
Prosaposin and prosaptide, a peptide from prosaposin, induce an increase in ganglioside content on NS20Y neuroblastoma cellsR Misasi, M Sorice, G S Carson, et al.Journal of Clinical Apheresis|January 1, 1995
Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infectionJ P Hester, M C Dignani, E J Anaissie, et al.Pageof 103